Hinge Health, Inc.
For the period ended Jul 29, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jul 29, 2026 · Filed Aug 4, 2026
Use the contents to explore the available documents and sections.
HNGE$115.76-0.2%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue | $212,817 | $139,098 | $395,124 | $262,923 |
| Cost of revenue | 28,868 | 41,335 | 56,942 | 64,927 |
| Gross profit | 183,949 | 97,763 | 338,182 | 197,996 |
| Operating expenses: | ||||
| Research and development | 34,057 | 279,962 | 64,395 | 303,462 |
| Sales and marketing | 81,408 | 147,228 | 150,210 | 193,944 |
| General and administrative | 28,044 | 251,244 | 51,068 | 268,125 |
| Total operating expenses | 143,509 | 678,434 | 265,673 | 765,531 |
| Income (loss) from operations | 40,440 | (580,671) | 72,509 | (567,535) |
| Other income: | ||||
| Other income, net | 3,990 | 4,694 | 7,863 | 9,695 |
| Net income (loss) before income taxes | 44,430 | (575,977) | 80,372 | (557,840) |
| Provision for (benefit from) income taxes | 740 | (326) | 1,554 | 672 |
| Net income (loss) | $43,690 | $(575,651) | $78,818 | $(558,512) |
| Adjustment to reflect deemed contribution from Series D and Series E redeemable convertible preferred stock extinguishment | — | — | — | 104,174 |
| Income allocated to participating securities | (588) | — | (1,784) | — |
| Net income (loss) attributable to common stockholders, basic | $43,102 | $(575,651) | $77,034 | $(454,338) |
| Net income (loss) attributable to common stockholders, diluted | $43,133 | $(575,651) | $77,109 | $(454,338) |
| Net income (loss) attributable to common stockholders per share: | ||||
| Basic | $0.55 | $(13.10) | $0.98 | $(15.05) |
| Diluted | $0.52 | $(13.10) | $0.94 | $(15.05) |
| Weighted average shares used in computing net income (loss) per share attributable to common stockholders: | ||||
| Basic | 78,969 | 43,931 | 78,795 | 30,190 |
| Diluted | 83,424 | 43,931 | 82,344 | 30,190 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.